FdaNdcDirectoryPulse / compare
BRYTLY vs CVS Calamine Plus Roll On: FdaNdcDirectoryPulse comparison
BRYTLY (2026-10-16) and CVS Calamine Plus Roll On (2026-09-30) are peer FdaNdcDirectoryPulse records.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Both records plus every comparable record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does BRYTLY compare to CVS Calamine Plus Roll On?
| Field | BRYTLY | CVS Calamine Plus Roll On |
|---|---|---|
| Product | BRYTLY | CVS Calamine Plus Roll On |
| Generic name | Apraclonidine Hydrochloride | zinc oxide, pramoxine hydrochloride |
| NDC | 0065-8596 | 51316-420 |
| Labeler | Alcon Laboratories, Inc. | CVS Pharmacy |
| Product type | HUMAN OTC DRUG | HUMAN OTC DRUG |
| Approval pathway | NDA | OTC MONOGRAPH DRUG |
| Application number | NDA220341 | M016 |
| Dosage form | SOLUTION/ DROPS | LOTION |
| Route | OPHTHALMIC | TOPICAL |
| Active ingredients | APRACLONIDINE HYDROCHLORIDE 1.25 mg/mL | ZINC OXIDE 80 mg/mL; PRAMOXINE HYDROCHLORIDE 10 mg/mL |
| Marketing start | 2026-10-16 | 2026-09-30 |
| Package configurations | 3 | 1 |
| Launch Signal Score | 45/100 | 15/100 |
| Peer rank and all 500 records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: BRYTLY · CVS Calamine Plus Roll On
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.